York Bridge Wealth Partners, LLC Immuno Gen, Inc. Transaction History

York Bridge Wealth Partners, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 21, 2019	SELL	$2.22 - $3.39 $4,011 - $6,125	-1,807 Closed	0 $0
Q2 2019 Jul 18, 2019	BUY	$1.8 - $3.3 $1,654 - $3,032	919 Added 103.49%	1,807 $4,000
Q1 2019 May 09, 2019	BUY	$2.41 - $5.91 $800 - $1,962	332 Added 59.71%	888 $2,000
Q4 2018 Feb 14, 2019	BUY	$3.94 - $9.7 $177 - $436	45 Added 8.81%	556 $3,000
Q3 2018 Nov 14, 2018	SELL	$8.6 - $11.26 $834 - $1,092	-97 Reduced 15.95%	511 $5,000
Q2 2018 Aug 10, 2018	SELL	$9.52 - $12.15 $894 - $1,142	-94 Reduced 13.39%	608 $6,000
Q1 2018 May 15, 2018	SELL	$6.7 - $12.95 $321 - $621	-48 Reduced 6.4%	702 $7,000
Q4 2017 Feb 12, 2018	SELL	$5.07 - $7.92 $3,985 - $6,225	-786 Reduced 51.17%	750 $6,000
Q3 2017 Oct 27, 2017	SELL	$5.4 - $8.47 $2,991 - $4,692	-554 Reduced 26.51%	1,536 $12,000
Q2 2017 Aug 14, 2017	BUY	N/A	2,090	2,090 $14,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of York Bridge Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on York Bridge Wealth Partners, LLC with notifications on news.